Previously Untreated and Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of Ipilimumab in the Immune System (NCT01715077) | University Health Network, Toronto | 2012-10-01 |
Track Previously Untreated and Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.